Skip to content

Benefit of Laparoscopic Adhesiolysis in Patients With Chronische Abdominal Pain

Benefit of Laparoscopic Adhesiolysis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02839564
Enrollment
100
Registered
2016-07-21
Start date
1997-08-31
Completion date
2014-01-31
Last updated
2016-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Adhesions

Keywords

chronic abdominal pain, laparoscopic adhesiolysis, placebo

Brief summary

Laparoscopic adhesiolysis as a therapy for chronic pain is still controversial and long term effects are not known. The objective was to to evaluate long term effects of laparoscopic adhesiolysis for treating chronic abdominal pain. Therefore one hundred patients with abdominal pain attributed to adhesions were randomized to laparoscopic adhesiolysis or a placebo group with laparoscopy alone. Pain relief was assessed after 3, 6 and 12 months and 12-year follow-up.

Detailed description

This multi-center randomized controlled trial, included patients with chronic abdominal pain likely to be caused by adhesions from previous abdominal surgery. Chronic abdominal pain was defined as continues or intermittent abdominal pain of at least six months' duration. After excluding other pathology (see exclusion criteria) included patients underwent a diagnostic laparoscopy to confirm the adhesions and to exclude serious morbidity not visible with other diagnostics. If during laparoscopy adhesions were the only pathology present, patients were randomly assigned either to laparoscopic adhesiolysis or no treatment. For the randomization and surgical procedures the investigators refer to the original article. Patients were unaware of their treatment assignment and the outcome assessment was blinded. Abdominal pain and quality of life (QOL) were assessed pre-operatively and at 3, 6 and 12 months of follow-using a visual analog scale (VAS), verbal rating pain change score (VRCS) and the short form 36 (SF-36). After twelve months randomization was disclosed and placebo group patients with persisting abdominal pain could request laparoscopic adhesiolysis. After twelve year follow-up pain, QOL, medical history and analgesic intake were analyzed to assess the long term effects of laparoscopic adhesiolysis.

Interventions

After diagnostic laparoscopy to confirm adhesions and exclude other pathology laparoscopic adhesiolysis was performed

After diagnostic laparoscopy to confirm adhesions and exclude other pathology treatment was stopped.

Sponsors

Erasmus Medical Center
CollaboratorOTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
Rijnstate Hospital
CollaboratorOTHER
Maxima Medical Center
CollaboratorOTHER
Catharina Ziekenhuis Eindhoven
CollaboratorOTHER
Maasstad Hospital
CollaboratorOTHER
Isala
CollaboratorOTHER
Groene Hart Ziekenhuis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 18 years and above with chronic abdominal pain that was likely to be caused by adhesions due to previous abdominal surgery were recruited. Before attributing abdominal pain to the existence of adhesions all patients had an extensional diagnostic work-up to exclude other pathology.

Exclusion criteria

* Current treatment by psychologist or psychiatrist * Use of laxatives, sedatives, morphine, antipsychotics, antidepressants, or drugs that stimulate the central nervous system * Abnormal outcome of standardized non-invasive diagnostics: * Biochemical investigation * Lactose tolerance tests or H2 respiration test * Feces analysis of worms and worm eggs * Ultrasound or CT scan of the abdomen * Radiographic studies of small and large bowel (or colonoscopy)

Design outcomes

Primary

MeasureTime frameDescription
Short term pain relief12 monthsPain relief was assessed using a verbal rating pain change score (VRCS)
Long term pain relief12 yearPain relief was assessed using a verbal rating pain change score (VRCS)

Secondary

MeasureTime frameDescription
Analgesic intake12 months and 12 year
Quality of life12 months and 12 yearQOL was assessed using the Short Form 36
rate of consulting medical doctors12 months and 12 year
additional surgery because of persisting abdominal pain12 months and 12 yearpatient questionnaire, patients medical record
Complications of treatment12 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026